According to a new report, published by KBV research, The Global Joint Pain Injections Market size is expected to reach $9.9 billion by 2028, rising at a market growth of 7.7% CAGR during the forecast period.
The Interleukin Inhibitors market has shown the high growth rate of 7.3 % during the forecast period. When traditional treatments for inflammatory diseases such as rheumatoid arthritis, psoriatic arthritis, and gout fail, IL inhibitors may lessen discomfort. The inclusion of IL inhibitors in clinical guidelines supported by the American College of Rheumatology (ACR) is anticipated to positively affect the segment's growth.
The Drug Stores & Retail Pharmacies market acquired the high revenue in the Global Joint Pain Injections Market by Distribution Channel in 2021, thereby, achieving a market value of $4.4 billion by 2028. This is owing to the adoption of cutting-edge joint pain treatment alternatives in hospitals as well as the simple accessibility of injections at the nearby drugstore. Also, these pharmacies are often dispersed across the neighbourhood for convenience, which is a major reason for fostering the segment's expansion.
The Facet Joints of the Spine market is showcasing a CAGR of 8.6% during (2022 - 2028). Facet joint injections work by temporarily injecting an anesthetic drug into the facet joint, which causes the ligaments, joints, and joint capsules to go numb. However, some people may experience adverse consequences from the corticosteroids in steroid injections, such as nerve damage, joint infection, thinning of adjacent bone, and allergic responses, which discourage people from choosing joint pain injections and restrain the market growth.
The North America market dominated the Global Joint Pain Injections Market by Region in 2021, and would continue to be a dominant market till 2028; thereby, achieving a market value of $3.9 billion by 2028. The Europe market is anticipated to grow at a CAGR of 7.2% during (2022 - 2028). Additionally, The Asia Pacific market would witness a CAGR of 8.6% during (2022 - 2028).
Full Report: https://www.kbvresearch.com/joint-pain-injections-market/
The market research report has exhaustive quantitative insights providing a clear picture of the market potential in various segments across the globe with country wise analysis in each discussed region. The key impacting factors of the market have been discussed in the report with the elaborated company profiles of Bioventus Inc., Pacira BioSciences, Inc., AbbVie, Inc., Teva Pharmaceuticals Industries Ltd., Pfizer, Inc., Anika Therapeutics, Inc., Zimmer Biomet Holdings, Inc., Eli Lilly And Company, Ferring Holdings SA, and Sanofi S.A.
By Injection Type
By Distribution Channel
By Joint Type
By Geography
Companies Profiled
Unique Offerings 
